Reporting a Phase II, Open-Label Study Assessing the Safety and Efficacy of MS1819-SD, a Recombinant Lipase, for the Treatment of Exocrine Pancreatic Insufficiency L. Lebreton,G. Smith,P. Jais, M. Schue, T. SpoorHPB(2019)引用 0|浏览9AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要